Drug recall
Methylprednisolone Acetate Injectable Suspension, USP 80mg/ml, 1 ml. The product is shipped as 25 single unit…
FDA recall event 44969 · Class II · TEVA Pharmaceuticals USA, Inc.
Key facts
| Event ID | 44969 |
|---|---|
| Recall numbers | D-028-2008 |
| Recalling firm | TEVA Pharmaceuticals USA, Inc. |
| Product type | Drugs |
| Products | Methylprednisolone Acetate Injectable Suspension, USP 80mg/ml, 1 ml. The product is shipped as 25 single unit vials or 40 twenty-five unit vials |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | lack of assurance of sterility |
| Initiation date | Sep 27, 2007 |
| Termination date | Jun 27, 2008 |
| City | Sellersville |
| State | PA |
| Country | United States |
| FEI number | 2517175 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports